Tumale, Glysa B.

HRN: 26-34-06  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2025
CEFUROXIME 1.5GM (VIAL)
06/24/2025
06/25/2025
IV
1.5 Grams
Q8
SP 1LTCS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines